Trials / Completed
CompletedNCT02554734
Pharmacokinetic Study in Healthy Volunteers
Pharmacokinetics of Levodopa After Repeated Doses of Carbidopa, ODM-104 and Levodopa: an Open, Randomised Study With Crossover Design in Healthy Males and Females
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Phase I open, randomized cross-over pharmacokinetic study.
Detailed description
The purpose of this study is to investigate the pharmacokinetics of levodopa, carbidopa, 3-OMD and ODM-104 after repeated doses of levodopa, carbidopa and ODM-104: an open, randomized, multicenter study with crossover design in healthy males and females.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levodopa, carbidopa, ODM-104 | |
| DRUG | levodopa, carbidopa, entacapone |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-09-18
- Last updated
- 2016-01-14
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT02554734. Inclusion in this directory is not an endorsement.